Skip to main content
. 2017 Jan 27;64(8):1074–1080. doi: 10.1093/cid/cix043

Table 3.

Sensitivity and Specificity of Serodiagnostic Algorithms for Acute Erythema Migrans

Sensitivity and Specificity First-Tier Tests Alone Modified 2-Tiered
Testing Protocols
Conventional
2-Tiered Testing
WCS EIA C6 VlsE CLIA WCS EIA f/b C6 EIA WCS EIA
f/b VlsE CLIA
VlsE CLIA f/b C6 EIA WCS EIA f/b IgM/IgG WBs
Sensitivity, %
 Acute-phase EM (n = 55) 49 [.02] 65 [<.0001] 55 [.003] 38 [.22] 36 [.30] 54 [.003] 25
 Convalescent-phase EM (n = 47) 77 [.05] 81 [.01] 72 [.13] 72 [.13] 66 [.40] 72 [.13] 55
Specificity, %
 Overall (n = 1277) 97.4 [<.0001] 98.4 [.02] 98.1 [.003] 99.5 [1.00] 99.5 [1.00] 99.3 [.63] 99.5

Bracketed numbers represent the P values for the comparison with conventional 2-tiered testing.

Abbreviations: CLIA, chemiluminescence immunoassay; EIA, enzyme immunoassay; EM, erythema migrans; f/b, followed by; IgG, immunoglobulin G; IgM, immunoglobulin M; VlsE, variable major protein-like sequence, expressed; WB, Western blot; WCS, whole-cell sonicate.